Mario Gabelli's CHE Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 21,786 shares of Chemed Corporation (CHE) worth $8.23 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in CHE, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 15,730 shares. Largest reduction occurred in Q2 2018, reducing 146,071 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Chemed Corporation (CHE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Chemed Corporation (CHE) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -590 | Reduce 2.64% | 21,786 | $377.74 |
| Q4 2025 | +1,928 | Add 9.43% | 22,376 | $427.86 |
| Q3 2025 | +168 | Add 0.83% | 20,448 | $447.74 |
| Q2 2025 | +373 | Add 1.87% | 20,280 | $486.93 |
| Q1 2025 | -1,377 | Reduce 6.47% | 19,907 | $615.32 |
| Q4 2024 | -323 | Reduce 1.49% | 21,284 | $529.80 |
| Q3 2024 | -220 | Reduce 1.01% | 21,607 | $600.97 |
| Q2 2024 | -1,335 | Reduce 5.76% | 21,827 | $542.58 |
| Q1 2024 | -1,047 | Reduce 4.32% | 23,162 | $641.93 |
| Q4 2023 | -950 | Reduce 3.78% | 24,209 | $584.75 |
| Q3 2023 | -6,599 | Reduce 20.78% | 25,159 | $519.70 |
| Q2 2023 | -1,807 | Reduce 5.38% | 31,758 | $541.67 |
| Q1 2023 | -8,358 | Reduce 19.94% | 33,565 | $537.75 |
| Q4 2022 | -420 | Reduce 0.99% | 41,923 | $510.43 |
| Q3 2022 | -2,510 | Reduce 5.60% | 42,343 | $436.55 |
| Q2 2022 | -1,150 | Reduce 2.50% | 44,853 | $469.40 |
| Q1 2022 | -2,068 | Reduce 4.30% | 46,003 | $506.55 |
| Q4 2021 | -905 | Reduce 1.85% | 48,071 | $529.03 |
| Q3 2021 | -4,558 | Reduce 8.51% | 48,976 | $465.13 |
| Q2 2021 | -2,263 | Reduce 4.06% | 53,534 | $474.50 |
| Q1 2021 | -2,845 | Reduce 4.85% | 55,797 | $459.83 |
| Q4 2020 | -3,849 | Reduce 6.16% | 58,642 | $532.60 |
| Q3 2020 | -6,294 | Reduce 9.15% | 62,491 | $480.36 |
| Q2 2020 | -12,758 | Reduce 15.65% | 68,785 | $451.07 |
| Q1 2020 | -12,519 | Reduce 13.31% | 81,543 | $433.19 |
| Q4 2019 | -6,505 | Reduce 6.47% | 94,062 | $439.26 |
| Q3 2019 | -37,272 | Reduce 27.04% | 100,567 | $417.57 |
| Q2 2019 | -36,779 | Reduce 21.06% | 137,839 | $360.84 |
| Q1 2019 | -7,350 | Reduce 4.04% | 174,618 | $320.07 |
| Q4 2018 | -20,891 | Reduce 10.30% | 181,968 | $283.28 |
| Q3 2018 | -79,371 | Reduce 28.12% | 202,859 | $319.58 |
| Q2 2018 | -146,071 | Reduce 34.10% | 282,230 | $321.81 |
| Q1 2018 | -68,869 | Reduce 13.85% | 428,301 | $272.86 |
| Q4 2017 | -30,034 | Reduce 5.70% | 497,170 | $243.02 |
| Q3 2017 | -29,280 | Reduce 5.26% | 527,204 | $202.05 |
| Q2 2017 | -40,016 | Reduce 6.71% | 556,484 | $204.53 |
| Q1 2017 | -29,991 | Reduce 4.79% | 596,500 | $182.69 |
| Q4 2016 | -9,081 | Reduce 1.43% | 626,491 | $160.41 |
| Q3 2016 | -8,435 | Reduce 1.31% | 635,572 | $141.07 |
| Q2 2016 | +2,940 | Add 0.46% | 644,007 | $136.31 |
| Q1 2016 | +1,753 | Add 0.27% | 641,067 | $135.45 |
| Q4 2015 | -24,020 | Reduce 3.62% | 639,314 | $149.80 |
| Q3 2015 | -38,585 | Reduce 5.50% | 663,334 | $133.47 |
| Q2 2015 | -18,774 | Reduce 2.60% | 701,919 | $131.10 |
| Q1 2015 | -27,993 | Reduce 3.74% | 720,693 | $119.40 |
| Q4 2014 | -45,147 | Reduce 5.69% | 748,686 | $105.67 |
| Q3 2014 | -41,592 | Reduce 4.98% | 793,833 | $102.90 |
| Q2 2014 | +12,410 | Add 1.51% | 835,425 | $93.72 |
| Q1 2014 | -58,683 | Reduce 6.66% | 823,015 | $89.45 |
| Q4 2013 | +6,065 | Add 0.69% | 881,698 | $76.62 |
| Q3 2013 | +15,730 | Add 1.83% | 875,633 | $71.50 |
| Q2 2013 | +859,903 | Add 0.00% | 859,903 | $72.43 |
Mario Gabelli's Chemed Corporation Investment FAQs
Mario Gabelli first purchased Chemed Corporation (CHE) in Q2 2013, acquiring 859,903 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Chemed Corporation (CHE) for 52 quarters since Q2 2013.
Mario Gabelli's largest addition to Chemed Corporation (CHE) was in Q2 2013, adding 859,903 shares worth $62.28 M.
According to the latest 13F filing for Q1 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 21,786 shares of Chemed Corporation (CHE), valued at approximately $8.23 M.
As of the Q1 2026 filing, Chemed Corporation (CHE) represents approximately 0.08% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Chemed Corporation (CHE) was 881,698 shares, as reported at the end of Q4 2013.